Citation Impact
Citing Papers
Effect of Chlorpromazine on the Behaviour of Chronically Overactive Psychotic Patients
1954
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
2022 StandoutNobel
The neurobiological consequences of early stress and childhood maltreatment
2003
Expanded diversity of Asgard archaea and their relationships with eukaryotes
2021 Nature
A Rating Scale for Drug-Induced Akathisia
1989 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Mapping brain asymmetry
2003 Standout
The role of the medicinal chemist in drug discovery — then and now
2004
Targeting the dopamine D2receptor in schizophrenia
2006
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial
1995
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
2009 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Classical fear conditioning in the anxiety disorders: a meta-analysis
2005
Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo
1994 StandoutNobel
Descending control of pain
2002 Standout
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
1994 StandoutNobel
Antipsychotic agents in the treatment of bipolar mania
2009
Schizophrenia
2009 Standout
The 'atypicality' of antipsychotics: a concept re-examined and re-defined
2009 Nobel
Neuroleptics and the neuroleptic‐induced deficit syndrome
1994
Neurobiology of Dopamine in Schizophrenia
2007
The status of spectral EEG abnormality as a diagnostic test for schizophrenia
2007
The adolescent brain and age-related behavioral manifestations
2000 Standout
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients
1988
A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health
2011 Standout
Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat
2001
Molecular characterization of the dopamine transporter
1993
Burden and consequences of child maltreatment in high-income countries
2008 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Phenothiazine: the seven lives of pharmacology's first lead structure
2011
From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis
2005
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
GPCR functional selectivity has therapeutic impact
2007
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Dopamine receptors and the dopamine hypothesis of schizophrenia
1987
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study
1993 StandoutNobel
Subgenual prefrontal cortex abnormalities in mood disorders
1997 StandoutNature
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Topographic EEG activations during timbre and pitch discrimination tasks using musical sounds
1995
Autoradiography of serotonin receptor subtypes in the central nervous system
1991
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging
1990
Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions
1999 Standout
Mapping dopamine receptors in the human brain
1988
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia
2006
Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs
1990
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
Plants and the central nervous system
2003 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypotalamo-pituitary-adrenal axes
1991
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
2004
Diagnosing the decline in pharmaceutical R&D efficiency
2012 Standout
Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232
1992 StandoutNobel
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
2007 Standout
Antioxidant Activity of Dietary Polyphenols As Determined by a Modified Ferric Reducing/Antioxidant Power Assay
2000 Standout
Developmental neurobiology of childhood stress and trauma
2002
Imaging Dopamine Receptors in the Human Brain by Positron Tomography
1983 Science
Major psychosis and dopamine: controversial features and some suggestions
1984
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Neurodegenerative Tauopathies
2001 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
CHLORPROMAZINE IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
1954
The surface activity of tranquilizers
1963
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Glucocorticoids, Transmitters and Stress
1992
STRESS AND HIPPOCAMPAL PLASTICITY
1999 Standout
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Comparison between Akathisia Developing on Treatment with Phenothiazine Derivatives and the Restless Legs Syndrome
1961
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
1978 Nature
Head circumference and incident Alzheimer’s disease
2001
How antipsychotics work—From receptors to reality
2006
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
2015 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
1980 Standout
Receptor mechanisms in antipsychotic drug action: focus on sigma receptors
1989
Atypical Antipsychotics: New Directions and New Challenges in the Treatment of Schizophrenia
2001
ACID PHOSPHATASE LOCALIZATION IN RABBIT EOSINOPHILS
1967 StandoutNobel
Haloperidol versus placebo for schizophrenia
2013
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness
1986
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
1986 Science
Dopamine Receptors: From Structure to Function
1998 Standout
Industry sponsorship and research outcome
2017 Standout
Adverse effects of anticholinergic medication on positive schizophrenic symptoms
1983
Neuropathology of older persons without cognitive impairment from two community-based studies
2006 Standout
Works of P Deniker being referenced
Cafeine et cartographie EEG: Effets d'une tache visuospatiale chez des volontaires sains. Strategie d'analyse des donnees electropharmacologiques
1988
The neuroleptics: a historical survey
1990
PSYCHOPHYSIOLOGIC ASPECTS OF THE NEW CHEMOTHERA-PEUTIC DRUGS IN PSYCHIATRY
1956
[Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)].
1952
[Suicide in epileptics].
1957
Intra‐ and interhemispheric EEG differences quantified by spectral analysis
1979
Neuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry.
1955
Méthodes chimiothérapiques en psychiatrie : les nouveaux médicaments psychotropes
1961
[Therapeutic method derived from hiberno-therapy in excitation and agitation states].
1952
[Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
1975
[Efficacy of tianeptine in the treatment of psychasthenia. A study versus placebo].
1994
Experimental neurological syndromes and thenew drug therapies in psychiatry
1960
Open clinical study of cis(Z)‐clopenthixol
1981
[Experimental neurological syndromes & psychiatric therapy. I. Neurological effects of a new important neuroleptic drug, RP 7843].
1959
Position of tianeptine among antidepressive chemotherapies.
1988
[Excito-motor syndrome provoked by neuroleptic drugs].
1957
[N-dimethylamino-prophylchlorophenothiazine (4560 RP) therapy of confusional states].
1952
[In vivo study of central serotoninergic receptors in man using positron tomography].
1985
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
1983
[Neuroplegics in psychiatric therapy].
1953
Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: Positron emission tomography studies
1979
[Antipsychotic drugs and drugs inducing psychoses].
1983
Dopaminergic receptor sites in human brain
1985